Japan Authorities Ready False Advertising Charges Against Novartis
This article was originally published in PharmAsia News
Japan's Health, Labor and Welfare Ministry plans to file a criminal complaint against Novartis Pharma K.K., the local unit of Swiss-based Novartis, charging it with false advertising involving clinical trials.
You may also be interested in...
A flurry of financial appointments has been seen across the off-patent industry, involving major players Dr Reddy’s, Biocon, Mayne Pharma and Xbrane Biopharma.
Aurobindo has agreed to sell its US-based Natrol dietary supplements business at a significant premium to the $132.5m it paid in late 2014, as the Indian firm continues to drive into complex formulations in the US, including injectables and biosimilars.
GlaxoSmithKline’s third quarter results included a 9% decline in sales in its vaccine business, but this was offset by tight cost controls and restructuring benefits; the company expects to continue investing in its pipeline and new product launches.